Figure 12.
Schematic representation of (a) Arg-Gly-Asp (RGD), (b) Leu-Asp-Val-Pro (LDVP) integrin-binding motifs, (c) cyclic peptide RGD inhibitor cilengitide, and (d) key structural features of RGD-binding site.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.